Calls for Proposals Overseas FY 2021 Advanced Research and Development Programs for Medical Innovation (AMED-CREST, PRIME) Term1

Change log

27th April, 2021
"Public offering content", ” Public invitation briefing”, and ” Reference” have been updated.

Outline

Status of Grants/Funding Opportunities Grants/Funding Opportunities
R&D phase Basic Study
Key Fields Innovation and Clinical Research Center Project
Submission Deadline 2021.5.11 Tue Noon (Japan standard time) No exceptions for delay
Contact
Division of Innovative Research and Development, Department of Innovation and Clinical Research Center
E-mail: kenkyuk-kobo “AT”amed.go.jp (Please replace “AT” with “@”)
Remarks:
Please contact us by e-mail using the above contact information.

Public offering content

There are two terms of FY2021 application depending on Research Areas.

Term1: The selection of proposals for FY2021 Existing Research Areas.
Term2: The selection of proposals for FY2021 New Research Areas.

Only the explanation of the term1 is shown here.

Understanding proteostasis and discovering innovative medical applications

Program Supervisor (PS): NAGATA Kazuhiro, Director General, JT Biohistory Research Hall
Program Officer (PO): ENDO Tamao, Senior Fellow, Tokyo Metropolitan Institute of Gerontology

We invite proposals for innovative basic research that takes a transdisciplinary approach with the goal of understanding protein denaturation, regeneration, aggregation, and degradation processes, in terms of an understanding of normal maturation processes and the relationship with disease.

Understanding of the biological phenomena and responses at the early life stages to improve the quality of health and medical care

Program Supervisor (PS): SASAKI Hiroyuki, Distinguished Professor, Medical Institute of Bioregulation, Kyushu University
Program Officer (PO): TAKEDA Hiroyuki, Professor, Graduate School of Science, The University of Tokyo

We invite proposals focusing on the development of a fundamental understanding of various biological phenomena at the early life stages and of a quantitative understanding of the impact of early exposure to environmental factors by combining a wide range of methods, including omics, imaging, and mathematical/data analysis. With this, we hope to generate seeds for better health and medical care in the future.

Solicitation Period

2021.3.23 Tue - 2021.5.11 Tue Noon (Japan standard time) No exceptions for delay

Interview Schedule

Interview Selection Meeting

Please confirm the details as indicated below. Only eligible participants will be notified it via an e-mail by a week before the interview.
Please understand we will not answer any questions regarding the selections and interviews.

Research and Development Area AMED-CREST PRIME
Understanding proteostasis and discovering innovative medical applications Thursday, July 29th
Occasional date: Aug 2nd
Friday, July 30th
Saturday, July 31st
Occasional date: Aug 2nd
Understanding of the biological phenomena and responses at the early life stages to improve the quality of health and medical care Friday, August 6th Wednesday, August 4th
Thursday, August 5th

Public invitation briefing

Recording of Public invitation briefing

Contents Briefing materials
Explanation of general rules of the program

Under preparation

【FY2020】
「Understanding proteostasis and discovering innovative medical applications」
Download
【FY2019】
「Understanding of the biological phenomena and responses at the early life
stages to improve the quality of health and medical care」
Download

How to Apply

Proposal Forms

Research and Development Area AMED-CREST PRIME
【FY2020】
Understanding proteostasis and discovering innovative medical applications

【FY2019】
Understanding of the biological phenomena and responses at the early life stages to improve the quality of health and medical care
Proposal Form E1
Proposal Form E2
Appendix E1
Appendix E2
Appendix E3
※Appendix E3 should be submitted in Excel format
Proposal-P(P1)
Summary of Proposal (Japanese)(Appendix P1)
Summary of Proposal(English)(Appendix P2)

Reference

2021.3.30

Last updated 2021.4.27